Literature DB >> 27272586

Treatment of Fatigue in Parkinson Disease.

Roy G Elbers1, Henk W Berendse2, Gert Kwakkel3.   

Abstract

CLINICAL QUESTION: Which pharmacological and nonpharmacological interventions are associated with improvement in general, physical, or mental fatigue and minimal adverse effects in patients with Parkinson disease (PD)? BOTTOM LINE: Rasagiline, modafinil, and doxepin are associated with improvement in fatigue and are not associated with increased risk of adverse effects in patients with PD. However, the quality of evidence is limited and does not provide a clear basis for treatment decisions.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27272586     DOI： 10.1001/jama.2016.5260

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


  8 in total

Review 1.  The ICM research agenda on intensive care unit-acquired weakness.

Authors:  Nicola Latronico; Margaret Herridge; Ramona O Hopkins; Derek Angus; Nicholas Hart; Greet Hermans; Theodore Iwashyna; Yaseen Arabi; Giuseppe Citerio; E. Wesley Ely; Jesse Hall; Sangeeta Mehta; Kathleen Puntillo; Johannes Van den Hoeven; Hannah Wunsch; Deborah Cook; Claudia Dos Santos; Gordon Rubenfeld; Jean-Louis Vincent; Greet Van den Berghe; Elie Azoulay; Dale M Needham
Journal:  Intensive Care Med       Date:  2017-03-13       Impact factor: 17.440

Review 2.  Fatigue as a symptom or comorbidity of neurological diseases.

Authors:  Iris-Katharina Penner; Friedemann Paul
Journal:  Nat Rev Neurol       Date:  2017-10-13       Impact factor: 42.937

3.  Prolonged Walking with a Wearable System Providing Intelligent Auditory Input in People with Parkinson's Disease.

Authors:  Pieter Ginis; Elke Heremans; Alberto Ferrari; Kim Dockx; Colleen G Canning; Alice Nieuwboer
Journal:  Front Neurol       Date:  2017-04-06       Impact factor: 4.003

4.  Validation of the Parkinson Fatigue Scale in Chinese Parkinson's disease patients.

Authors:  Rao Fu; Shi-Shuang Cui; Juan-Juan Du; Pei Huang; Ya-Chao He; Chao Gao; Xiao-Guang Luo; Sheng-Di Chen
Journal:  Brain Behav       Date:  2017-05-02       Impact factor: 2.708

5.  Fatigue in Parkinson's Disease Associates with Lower Ambulatory Diastolic Blood Pressure.

Authors:  Vikas Kotagal; Ashley Szpara; Roger L Albin; Nicolaas I Bohnen
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

6.  Association between fatigue and motor progression in Parkinson's disease in southern Chinese.

Authors:  Hong-Xiang Yu; Meng-Ruo Guo; Gang Li; Bei Zhang
Journal:  Neurol Sci       Date:  2019-09-04       Impact factor: 3.307

7.  Managing Fatigue in Parkinson's Disease: Protocol for a Pilot Randomized Controlled Trial.

Authors:  Neda Alizadeh; Tanya L Packer; Ingrid Sturkenboom; Gail Eskes; Grace Warner
Journal:  Can J Occup Ther       Date:  2022-03-15       Impact factor: 1.630

8.  The dimensionality of fatigue in Parkinson's disease.

Authors:  Raymond Chong; Lauren Albor; Chandramohan Wakade; John Morgan
Journal:  J Transl Med       Date:  2018-07-11       Impact factor: 5.531
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.